Literature DB >> 15604905

Clinical approach to cutaneous vasculitis.

Miguel A Gonzalez-Gay1, Carlos Garcia-Porrua, Ramon M Pujol.   

Abstract

PURPOSE OF REVIEW: This review provides the readers with an update on the clinical approach of a patient seeking treatment with cutaneous vasculitis. It outlines the work-up for assessing patients with cutaneous vasculitis and discusses the essential features of the main conditions included within this category. RECENT
FINDINGS: Recent works on genetic and infectious factors implicated in the pathogenesis of Henoch-Schonlein purpura are discussed. Special attention is given to the prognosis and response to treatment. Also, recent reports on cutaneous vasculitis secondary to connective tissue diseases are reviewed.
SUMMARY: With this review, the reader will be able to establish the steps to be followed in the clinical approach to a patient seeking treatment with cutaneous vasculitis.

Entities:  

Mesh:

Year:  2005        PMID: 15604905     DOI: 10.1097/01.bor.0000145519.68725.5a

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  11 in total

1.  Cutaneous vasculitis in systemic lupus erythematosus: association with anti-ribosomal P protein antibody and Raynaud phenomenon.

Authors:  Samuel Katsuyuki Shinjo; Eloísa Bonfá
Journal:  Clin Rheumatol       Date:  2010-03-28       Impact factor: 2.980

Review 2.  Cutaneous vasculitis.

Authors:  Samina Hayat; Seth Mark Berney
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

Review 3.  Cryoglobulinaemic vasculitis: classification and clinical and therapeutic aspects.

Authors:  Gerald S Braun; Sophia Horster; Katrin S Wagner; Stephan Ihrler; Holger Schmid
Journal:  Postgrad Med J       Date:  2007-02       Impact factor: 2.401

4.  Increased levels of rheumatoid factors after TNF inhibitor in rheumatoid arthritis.

Authors:  José Alexandre Mendonça; João Francisco Marques-Neto; Adil Muhib Samara; Simone Appenzeller
Journal:  Rheumatol Int       Date:  2011-02-15       Impact factor: 2.631

Review 5.  IgA Vasculitis: Genetics and Clinical and Therapeutic Management.

Authors:  Miguel A González-Gay; Raquel López-Mejías; Trinitario Pina; Ricardo Blanco; Santos Castañeda
Journal:  Curr Rheumatol Rep       Date:  2018-04-02       Impact factor: 4.592

6.  Connective tissue ulcers.

Authors:  Ganary Dabiri; Vincent Falanga
Journal:  J Tissue Viability       Date:  2013-06-10       Impact factor: 2.932

Review 7.  Vasculitis induced by tumor necrosis factor-targeted therapies.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Maria-Jose Cuadrado; Munther A Khamashta
Journal:  Curr Rheumatol Rep       Date:  2008-12       Impact factor: 4.592

Review 8.  Cutaneous vasculitis: a rheumatologist perspective.

Authors:  Trinitario Pina; Ricardo Blanco; Miguel A González-Gay
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.919

9.  Anti-TNF-Related Leukocytoclastic Vasculitis in Ulcerative Colitis: A Case Report.

Authors:  Valentina Giorgio; Elisa Blasi; Donato Rigante; Cristina Guerriero; Clara De Simone; Anna Laura Fedele; Giuseppe Stella; Antonio Gasbarrini; Franco Scaldaferri
Journal:  Int J Environ Res Public Health       Date:  2021-06-22       Impact factor: 3.390

10.  Cutaneous leukocytoclastic vasculitis associated with levofloxacin therapy.

Authors:  Dana M Blyth; Elizabeth Markelz; Jason F Okulicz
Journal:  Infect Dis Rep       Date:  2012-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.